CoChat

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: We sought to determine whether an oral disposition index (DI(O)) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DI(O) by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and beta-cell function. RESEARCH DESIGN AND METHODS: A total of 613 Japanese-American subjects (322 men and 291 women) underwent a 75-g oral glucose tolerance test (OGTT) at baseline, 5 years, and 10 years. Insulin sensitivity was estimated as 1/fasting insulin or homeostasis model assessment of insulin sensitivity (HOMA-S). Insulin response was estimated as the change in insulin divided by change in glucose from 0 to 30 min (DeltaI(0-30)/DeltaG(0-30)). RESULTS: DeltaI(0-30)/DeltaG(0-30) demonstrated a curvilinear relationship with 1/fasting insulin and HOMA-S with a left and downward shift as glucose tolerance deteriorated. The confidence limits for the slope of the log(e)-transformed estimates included -1 for DeltaI(0-30)/DeltaG(0-30) versus 1/fasting insulin for all glucose tolerance groups, consistent with a hyperbolic relationship. When HOMA-S was used as the insulin sensitivity measure, the confidence limits for the slope included -1 only for subjects with normal glucose tolerance (NGT) or impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) but not diabetes. On the basis of this hyperbolic relationship, the product of DeltaI(0-30)/DeltaG(0-30) and 1/fasting insulin was calculated (DI(O)) and decreased from NGT to IFG/IGT to diabetes (P < 0.001). Among nondiabetic subjects at baseline, baseline DI(O) predicted cumulative diabetes at 10 years (P < 0.001) independent of age, sex, BMI, family history of diabetes, and baseline fasting and 2-h glucose concentrations. CONCLUSIONS: The DI(O) provides a measure of beta-cell function adjusted for insulin sensitivity and is predictive of development of diabetes over 10 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc08-1478

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The computed slopes (——) and 95% CIs for the slopes (– – –) for ln(ΔI0–30/ΔG0–30) versus ln(1/fasting insulin) are plotted for subjects with NGT (slope −0.87 [95% CI −1.13 to −0.61]) (A), IGM (−0.84 [−1.05 to −0.63]) (B), and diabetes (DM) (−0.76 [−1.16 to −0.35]) (C). D: The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of −1, are plotted for ΔI0–30/ΔG0–30 versus 1/fasting insulin.
Figure 1 The computed slopes (——) and 95% CIs for the slopes (– – –) for ln(ΔI0–30/ΔG0–30) versus ln(1/fasting insulin) are plotted for subjects with NGT (slope −0.87 [95% CI −1.13 to −0.61]) (A), IGM (−0.84 [−1.05 to −0.63]) (B), and diabetes (DM) (−0.76 [−1.16 to −0.35]) (C). D: The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of −1, are plotted for ΔI0–30/ΔG0–30 versus 1/fasting insulin.CC BY-NC-ND · PubMed Central
Figure 2 A: The DIO (ΔI0–30/ΔG0–30 × 1/fasting insulin) decreases from NGT to IGM to diabetes (DM) (median [interquartile range]). B: The logarithmic means for baseline ΔI0–30/ΔG0–30 and 1/fasting insulin values are plotted for subjects with NGT (▪ and □) and IGM (• and ○) as nonprogressors (▪ and •) and progressors (□ and ○) relative to the hyperbolic curves. Progressors had lower β-cell function at baseline. C: The number of subjects who developed diabetes over the 10-year follow-up period by quintiles of baseline DIO. D: ROC curves comparing ability of baseline ΔI0–30/ΔG0–30 (dotted line), 1/fasting insulin (dashed line), and DIO (solid line) to predict cumulative diabetes at 10 years.
Figure 2 A: The DIO (ΔI0–30/ΔG0–30 × 1/fasting insulin) decreases from NGT to IGM to diabetes (DM) (median [interquartile range]). B: The logarithmic means for baseline ΔI0–30/ΔG0–30 and 1/fasting insulin values are plotted for subjects with NGT (▪ and □) and IGM (• and ○) as nonprogressors (▪ and •) and progressors (□ and ○) relative to the hyperbolic curves. Progressors had lower β-cell function at baseline. C: The number of subjects who developed diabetes over the 10-year follow-up period by quintiles of baseline DIO. D: ROC curves comparing ability of baseline ΔI0–30/ΔG0–30 (dotted line), 1/fasting insulin (dashed line), and DIO (solid line) to predict cumulative diabetes at 10 years.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

Items 401–500 of 569

Metadata

Authors
Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E.
Affiliations
  • University of Washington (US)
  • University of Maryland, Baltimore (US)
  • VA Puget Sound Health Care System (US)
Venue
Diabetes Care
Published
2009-02-01
Volume
32
Issue
2
Pages
335-341
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2121328463
Cited by
572
References
27
Citations by year
2026: 24 · 2025: 30 · 2024: 39 · 2023: 41 · 2022: 40 · 2021: 44 · 2020: 41 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 42 · 2015: 26 · 2014: 35 · 2013: 29 · 2012: 35
FWCI
13.31
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (P30 DK, HL‐49293, DK-31170)
  • National Heart, Lung, and Blood Institute (R01HL049293)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, P30-DK 17047, K24DK002654, DK 02654, R01DK031170, P30DK035816, P30DK017047)
  • National Center for Research Resources (RR00037, M01RR000037)
  • NIH Clinical Center (RR-00037)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
oral disposition index, diabetes prediction, beta-cell function, insulin sensitivity, hyperbolic relationship, oral glucose tolerance test, impaired fasting glucose, impaired glucose tolerance, HOMA-S, fasting insulin
MeSH terms
Blood Glucose, Diabetes Mellitus, Fasting, Feedback, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Predictive Value of Tests, Regression Analysis, Time Factors, Reproducibility of Results, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.